Clorox Reports Q1 Fiscal Year 2023 Results, Confirms Outlook
The Clorox Company (CLX) reported a 4% decrease in net sales to $1.74 billion for Q1 FY2023, primarily due to lower volumes, despite a favorable price mix. Diluted EPS fell 40% to 68 cents, impacted by investments in digital capabilities and operating model changes. Adjusted EPS decreased 23% to 93 cents. Gross margin dropped to 36% amid rising manufacturing costs. The company maintains its FY2023 sales outlook, projecting a 2% increase and aiming for a gross margin improvement of 200 basis points.
- Year-to-date net cash provided by operations increased 334% to $178 million.
- Confirmed FY2023 sales outlook with net sales expected to increase 2% from the previous year.
- Net sales decreased 4% compared to the previous year.
- Diluted EPS decreased 40% to 68 cents.
OAKLAND, Calif., Nov. 1, 2022 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today reported results for the first quarter of fiscal year 2023, which ended Sept. 30, 2022.
Following is a summary of key first-quarter results. All comparisons are with the first quarter of fiscal year 2022 unless otherwise stated.
- Net sales decreased
4% to$1.74 billion compared to a6% net sales decrease in the year-ago quarter. The net sales decrease was driven largely by lower volume, partially offset by favorable price mix. Organic sales1 were down2% . The three-year average growth rate for net sales was up5% . - Gross margin decreased 110 basis points to
36% from37.1% in the year-ago quarter, due to higher manufacturing and logistics costs, higher commodity costs, and lower volume, partially offset by the benefits of pricing and cost savings initiatives. - Diluted net earnings per share (diluted EPS) decreased
40% to 68 cents from$1.14 in the year-ago quarter. This includes 13 cents related to investments in the company's long-term strategic digital capabilities and productivity enhancements as well as 12 cents related to implementation of its streamlined operating model. - Adjusted EPS1 decreased
23% to 93 cents from$1.21 in the year-ago quarter, due mainly to lower gross margin, lower volume, and higher selling and administrative expenses, partially offset by the benefits of pricing. - Year-to-date net cash provided by operations was
$178 million compared to$41 million in the year-ago period, representing a334% increase.
"We delivered better-than-expected results this quarter in a challenging operating environment, which reflects the strength of our brands and strong execution," said CEO Linda Rendle. "Looking ahead, we expect to face ongoing macro headwinds and will adapt with agility. Given these factors, we are maintaining our outlook for the year. We will continue to focus on rebuilding margin, investing in consumer-inspired innovation and driving our transformation forward to build a stronger, more resilient company."
This press release includes certain non-GAAP financial measures. See "Non-GAAP Financial Information" at the end of this press release for more details.
1 | Organic sales growth/(decrease) and adjusted EPS are non-GAAP measures. See Non-GAAP Financial Information at the end of this press release for reconciliations to the most comparable GAAP measures. | |||||||||
The following are recent highlights of business and ESG achievements:
- Continued to execute cost-justified pricing actions across the vast majority of the portfolio.
- Achieved total distribution point share growth for an eighth consecutive quarter.
- Delivered highest value for cost-savings initiatives in three years.
- Grew all-outlet share in the company's four largest businesses.
- Opened a new cat litter manufacturing facility in Martinsburg, West Virginia, in October, with production starting in January 2023 and shipments in February 2023.
- Launched Clorox EcoClean innovation platform, a new line of eco-conscious disinfectants and cleaners made with ingredients certified by the U.S. Environmental Protection Agency's Design for the Environment and Safer Choice programs in packaging with at least
25% post-consumer recycled plastic. - Launched a data hub giving stakeholders enhanced visibility into ESG performance, including publication of a new climate action plan, to further advance the company's reporting processes and data governance efforts.
The following is a summary of key first-quarter results by reportable segment. All comparisons are with the first quarter of fiscal year 2022, unless otherwise stated.
Health and Wellness (Cleaning; Professional Products; Vitamins, Minerals and Supplements)
- Net sales decreased
4% , with 17 points of favorable price mix more than offset by 21 points of lower volume. - Cleaning sales decreased, primarily as a result of ongoing normalization of consumer demand, which was partially offset by a stronger-than-anticipated consumer response to a successful back-to-school merchandising program.
- Professional Products sales were flat, as favorable price mix was offset by a volume decrease due to the normalization of demand from the COVID-19 delta variant in the year-ago quarter.
- VMS sales decreased, primarily due to a reduction in inventory levels at select retailers as well as the business's ongoing shift away from noncore brands.
- Segment pretax earnings increased
10% , primarily behind favorable price mix and lower advertising spending, which were partially offset by lower volume, costs associated with the voluntary recall of certain Pine-Sol scented products and higher commodity costs.
Household (Bags and Wraps; Grilling; Cat Litter)
- Net sales decreased
4% , with 10 points of benefit from favorable price mix more than offset by 14 points of lower volume. - Bags and Wraps sales were down as a result of supply chain disruptions, partially offset by ongoing momentum behind innovation such as Glad ForceFlex Plus Trash Bags with Cherry Blossom scent.
- Grilling sales decreased due to ongoing normalization of consumer demand after the business saw a surge during the peak of the pandemic. Sales this quarter also were impacted by retailer inventory adjustments.
- Cat Litter sales increased, driven mainly by strong category growth and the Fresh Step Outstretch innovation.
- Segment pretax earnings decreased
39% , primarily due to higher manufacturing and logistics costs and higher commodity costs, which were partially offset by the net impact of pricing.
Lifestyle (Food, Natural Personal Care, Water Filtration)
- Net sales decreased
3% , with 7 points of favorable price mix more than offset by 10 points of lower volume. - Food sales were up, benefiting from continued strong consumption supported by merchandising activities to expand consumer usage of bottled Hidden Valley Ranch to new occasions.
- Natural Personal Care sales decreased due to lower shipments caused by supply chain disruptions.
- Water Filtration sales were down as the business lapped strong shipments in the year-ago quarter after recording strong double-digit sales growth over the last two years.
- Segment pretax earnings decreased
35% , mainly due to higher commodity costs, higher manufacturing and logistics costs, and supply chain disruptions in Natural Personal Care.
International (Sales Outside the U.S.)
- Net sales decreased
1% , with 4 points of lower volume and 9 points of unfavorable foreign exchange rates partially offset by 12 points of favorable price mix. Organic sales growth was8% . The ongoing normalization of cleaning globally also contributed to lower sales. - Segment pretax earnings decreased
23% behind unfavorable foreign exchange rates, higher manufacturing and logistics costs, and higher commodity costs, which were partially offset by the net impact of pricing.
Fiscal Year 2023 Outlook
The company is confirming its fiscal year 2023 outlook with the following elements:
- Net sales from a
4% decrease to a2% increase compared to the prior year (organic sales from a3% decrease to a3% increase). - Foreign exchange headwinds now represent about a 2-point reduction in sales from 1.5 points assumed in the prior outlook.
- Gross margin increase of about 200 basis points, primarily due to the combined benefit of pricing, cost savings and supply chain optimization, offset by continued cost inflation.
- Selling and administrative expenses between
15% and16% of net sales, including about 1.5 points of impact from the company's strategic investments in digital capabilities and productivity enhancements. - Advertising and sales promotion spending of about
10% of net sales, reflecting the company's ongoing commitment to invest in its brands. - Effective tax rate of about
24% , with year-over-year increase primarily reflecting lower excess tax benefits from equity compensation. - Diluted EPS between
$3.10 and$3.47 , or a17% to7% decrease, respectively. - Adjusted EPS between
$3.85 and$4.22 , or a6% decrease to a3% increase, respectively. It reflects continued normalization of demand in parts of the portfolio that saw the most significant surge over the last two years and progress rebuilding gross margin. It also reflects the company's long-standing commitment to continue investing in its brands as well as a return to more normalized levels of incentive compensation and a higher effective tax rate. To provide greater visibility into the underlying operating performance of the business, adjusted EPS outlook excludes the long-term strategic investment in digital capabilities and productivity enhancements, estimated to be about 55 cents, and an estimated 20-cent charge related to the previously announced streamlined operating model.
At approximately 4:15 p.m. ET today, Clorox will post prepared management remarks regarding its first-quarter fiscal year 2023 results.
At 5 p.m. ET today, the company will host a live Q&A audio webcast with CEO Linda Rendle and Chief Financial Officer Kevin Jacobsen to discuss the results.
Links to the live (and archived) webcast, press release and prepared remarks can be found at Clorox Quarterly Results.
Visit the company's Quarterly Results for the following:
- Supplemental unaudited volume and sales growth information
- Supplemental unaudited gross margin driver information
- Supplemental unaudited cash flow information and free cash flow reconciliation
- Supplemental unaudited reconciliation of earnings before interest and taxes (EBIT) and adjusted EBIT
- Supplemental unaudited reconciliation of adjusted earnings per share
Note: Percentage and basis-point, or point, changes noted in this press release are calculated based on rounded numbers, except for per-share data and the effective tax rate.
The Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Its trusted brands, which include Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr®, Pine-Sol® and Rainbow Light®, can be found in about nine of 10 U.S. homes and internationally with brands such as Ajudin®, Clorinda®, Chux® and Poett®. Headquartered in Oakland, California, since 1913, Clorox was one of the first U.S. companies to integrate ESG into its business reporting, with commitments in three areas: Healthy Lives, Clean World and Thriving Communities. Visit thecloroxcompany.com to learn more.
CLX-F
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements related to the expected or potential impact of the novel coronavirus (COVID-19) pandemic, and the related responses of governments, consumers, customers, suppliers, employees and the company, on our business, operations, employees, financial condition and results of operations, and any such forward-looking statements, whether concerning the COVID-19 pandemic or otherwise, involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, organic sales growth, foreign currencies, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, foreign currency exchange rates, tax rates, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management's estimates, beliefs, assumptions and projections. Words such as "could," "may," "expects," "anticipates," "targets," "goals," "projects," "intends," "plans," "believes," "seeks," "estimates," "will," "predicts," and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management's expectations are described in the sections entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's Annual Report on Form 10-K for the fiscal year ended June 30, 2022, as updated from time to time in the company's Securities and Exchange Commission filings. These factors include, but are not limited to: the impact of the changing retail environment, including the growth of alternative retail channels and business models, and changing consumer preferences; volatility and increases in the costs of raw materials, energy, transportation, labor and other necessary supplies or services; the ability of the company to drive sales growth, increase prices and market share, grow its product categories and manage favorable product and geographic mix; risks related to supply chain issues, product shortages and disruptions to the business, as a result of increased supply chain dependencies due to an expanded supplier network and a reliance on certain single-source suppliers; the ongoing COVID-19 pandemic and related impacts, including on the availability of, and efficiency of the supply, manufacturing and distribution systems for, the company's products, including any significant disruption to such systems; on the demand for and sales of the company's products; and on worldwide, regional and local adverse economic conditions; intense competition in the company's markets; unfavorable general economic and political conditions beyond our control, including recent supply chain disruptions, labor shortages, wage pressures, rising inflation, fuel and energy costs, foreign currency exchange rate fluctuations, weather events or natural disasters, disease outbreaks or pandemics, such as COVID-19, terrorism, and unstable geopolitical conditions, including the conflict in Ukraine; risks related to the company's use of and reliance on information technology systems, including potential security breaches, cyber-attacks, privacy breaches or data breaches that result in the unauthorized disclosure of consumer, customer, employee or company information, or service interruptions, especially at a time when a large number of the company's employees are working remotely and accessing its technology infrastructure remotely; the ability of the company to implement and generate cost savings and efficiencies, and successfully implement its business strategies, including achieving anticipated results and cost savings from the implementation of the streamlined operating model; dependence on key customers and risks related to customer consolidation and ordering patterns; the company's ability to attract and retain key personnel, which may continue to be impacted by challenges in the labor market, such as wage inflation and sustained labor shortages; the company's ability to maintain its business reputation and the reputation of its brands and products; lower revenue, increased costs or reputational harm resulting from government actions and compliance with regulations, or any material costs imposed by changes in regulation; the ability of the company to successfully manage global political, legal, tax and regulatory risks, including changes in regulatory or administrative activity; risks related to international operations and international trade, including changing macroeconomic conditions as a result of inflation, volatile commodity prices and increases in raw and packaging materials prices, labor, energy and logistics; global economic or political instability; foreign currency fluctuations, such as devaluations, and foreign currency exchange rate controls; changes in governmental policies, including trade, travel or immigration restrictions, new or additional tariffs, and price or other controls; labor claims and civil unrest; continued high levels of inflation in Argentina; potential disruption from wars and military conflicts, including the conflict in Ukraine; impact of the United Kingdom's exit from the European Union; potential negative impact and liabilities from the use, storage and transportation of chlorine in certain international markets where chlorine is used in the production of bleach; widespread health emergencies, such as COVID-19; and the possibility of nationalization, expropriation of assets or other government action; the impact of Environmental, Social, and Governance (ESG) issues, including those related to climate change and sustainability on our sales, operating costs or reputation; the ability of the company to innovate and to develop and introduce commercially successful products, or expand into adjacent categories and countries; the impact of product liability claims, labor claims and other legal, governmental or tax proceedings, including in foreign jurisdictions and in connection with any product recalls; risks relating to acquisitions, new ventures and divestitures, and associated costs; and the ability to complete announced transactions and, if completed, integration costs and potential contingent liabilities related to those transactions; the accuracy of the company's estimates and assumptions on which its financial projections, including any sales or earnings guidance or outlook it may provide from time to time, are based; risks related to additional increases in the estimated fair value of The Procter & Gamble Company's interest in the Glad business; environmental matters, including costs associated with the remediation and monitoring of past contamination, and possible increases in costs resulting from actions by relevant regulators, and the handling and/or transportation of hazardous substances; the company's ability to effectively utilize, assert and defend its intellectual property rights, and any infringement or claimed infringement by the company of third-party intellectual property rights; the performance of strategic alliances and other business relationships; the effect of the company's indebtedness and credit rating on its business operations and financial results and the company's ability to access capital markets and other funding sources; the company's ability to pay and declare dividends or repurchase its stock in the future; the impacts of potential stockholder activism; and risks related to any litigation associated with the exclusive forum provision in the company's bylaws.
The company's forward-looking statements in this press release are based on management's current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this press release. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.
- This press release contains non-GAAP financial information related to organic sales growth/(decrease) and adjusted EPS for the first quarter of fiscal year 2023, as well as organic sales growth/(decrease) and adjusted EPS outlook for fiscal year 2023.
- Clorox defines organic sales growth/(decrease) as GAAP net sales growth/(decrease) excluding the effect of foreign exchange rate changes and any acquisitions or divestitures.
- Organic sales growth/(decrease) outlook for fiscal year 2023 excludes the impact of foreign currency exchange rate changes, which the company currently expects to reduce GAAP net sales growth/(decrease) by about 2 percentage points.
- Management believes that the presentation of organic sales growth/(decrease) is useful to investors because it excludes sales from any acquisitions and divestitures, which results in a comparison of sales only from the businesses that the company was operating and expects to continue to operate throughout the relevant periods, and the company's estimate of the impact of foreign exchange rate changes, which are difficult to predict and out of the control of the company and management. However, organic sales growth/(decrease) may not be the same as similar measures provided by other companies due to potential differences in methods of calculation or differences in which items are incorporated into these adjustments.
- Adjusted EPS is defined as diluted earnings per share that excludes or has otherwise been adjusted for significant items that are nonrecurring or unusual. The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
- Adjusted EPS is supplemental information that management uses to help evaluate the company's historical and prospective financial performance on a consistent basis over time. Management believes that by adjusting for certain items affecting comparability of performance over time, such as asset impairments, charges related to the streamlined operating model, charges related to the digital capabilities and productivity enhancements investment, significant losses/(gains) related to acquisitions and other nonrecurring or unusual items, investors and management are able to gain additional insight into the company's underlying operating performance on a consistent basis over time. However, adjusted EPS may not be the same as similar measures provided by other companies due to potential differences in methods of calculation or differences in which items are incorporated into these adjustments.
- The reconciliation tables below refer to the equivalent GAAP measures adjusted as applicable for the following items:
As announced in August 2021, the company plans to invest approximately
Of the total
Due to the nature, scope and magnitude of this investment, these costs are considered by management to represent incremental transformational costs above the historical normal level of spending for information technology to support operations. Since these strategic investments, including incremental operating costs, will cease at the end of the investment period, are not expected to recur in the foreseeable future and are not considered representative of the company's underlying operating performance, the company's management believes presenting these costs as an adjustment in the non-GAAP results provides additional information to investors about trends in the company's operations and is useful for period-over-period comparisons. It also allows investors to view underlying operating results in the same manner as they are viewed by company management.
As announced in August 2022, Clorox began to implement a streamlined operating model in the first quarter of fiscal year 2023. This quarter, the company began recognizing costs related to implementation of this model to meet its objectives of driving growth and productivity. The streamlined operating model is expected to enhance the company's ability to respond more quickly to changing consumer behaviors and innovate faster. Related costs are primarily expected to include employee-related costs to reduce certain staffing levels, such as severance payments, as well as for consulting and other costs. The company anticipates that the implementation of this new model will be completed in fiscal year 2024, with different phases occurring throughout the implementation period. As a result, the company expects to incur costs of approximately
The following tables provide reconciliations of organic sales growth/(decrease) (non-GAAP) to net sales growth/(decrease), the most comparable GAAP measure:
Three Months Ended September 30, 2022 | |||||||||
Percentage change versus the year-ago period | |||||||||
Health and | Household | Lifestyle | International | Total | |||||
Net sales growth / (decrease) (GAAP) | (4) % | (4) % | (3) % | (1) % | (4) % | ||||
Add: Foreign Exchange | — | — | — | 9 | 2 | ||||
Add/(Subtract): Divestitures/Acquisitions | — | — | — | — | — | ||||
Organic sales growth / (decrease) (non-GAAP) | (4) % | (4) % | (3) % | 8 % | (2) % | ||||
The following tables provide reconciliations of adjusted diluted earnings per share (non-GAAP) to diluted earnings per share, the most comparable GAAP measure:
Adjusted Diluted Earnings Per Share (EPS) | ||||||||
(Dollars in millions except per share data) | ||||||||
Diluted Earnings Per Share | ||||||||
Three Months Ended September 30 | ||||||||
2022 | 2021 | % Change | ||||||
As reported (GAAP) | $ 0.68 | $ 1.14 | (40) % | |||||
Streamlined operating model (1) | 0.12 | — | ||||||
Digital capabilities and productivity enhancements | 0.13 | 0.07 | ||||||
As adjusted (Non-GAAP) | $ 0.93 | $ 1.21 | (23) % | |||||
(1) During the three months ended September 30, 2022, the company incurred approximately | ||||||||
(2) During the three months ended September 30, 2022 and 2021, the company incurred approximately | ||||||||
Three Months Ended September 30 | ||||||||
2022 | 2021 | |||||||
External consulting fees (a) | $ 16 | $ 9 | ||||||
IT project personnel costs (b) | 1 | 3 | ||||||
Other (c) | 3 | — | ||||||
Total | $ 20 | $ 12 | ||||||
(a) Comprised of third-party consulting fees incurred to assist in the project management and the preliminary project stage of this | ||||||||
(b) Comprised of labor costs associated with internal IT project management teams that are utilized to oversee the new system | ||||||||
(c) Comprised of various other expenses associated with the company's new system implementations, including company | ||||||||
Full Year 2023 Outlook (Estimated Range) | ||||||||
Diluted Earnings Per Share | ||||||||
Low | High | |||||||
As estimated (GAAP) | $ 3.10 | $ 3.47 | ||||||
Streamlined operating model (3) | 0.20 | 0.20 | ||||||
Digital capabilities and productivity enhancements | 0.55 | 0.55 | ||||||
As adjusted (Non-GAAP) | $ 3.85 | $ 4.22 | ||||||
(3) In FY23, the company expects to incur approximately | ||||||||
(4) In FY23, the company expects to incur approximately | ||||||||
Condensed Consolidated Statements of Earnings (Unaudited) | |||||
Dollars in millions, except per share data | |||||
Three Months Ended | |||||
09/30/2022 | 09/30/2021 | ||||
Net sales | $ 1,740 | $ 1,806 | |||
Cost of products sold | 1,114 | 1,136 | |||
Gross profit | 626 | 670 | |||
Selling and administrative expenses | 261 | 236 | |||
Advertising costs | 161 | 182 | |||
Research and development costs | 32 | 33 | |||
Interest expense | 22 | 25 | |||
Other (income) expense, net | 34 | 9 | |||
Earnings before income taxes | 116 | 185 | |||
Income taxes | 29 | 42 | |||
Net earnings | 87 | 143 | |||
Less: Net earnings attributable to noncontrolling interests | 2 | 1 | |||
Net earnings attributable to Clorox | $ 85 | $ 142 | |||
Net earnings per share attributable to Clorox | |||||
Basic net earnings per share | $ 0.69 | $ 1.15 | |||
Diluted net earnings per share | $ 0.68 | $ 1.14 | |||
Weighted average shares outstanding (in thousands) | |||||
Basic | 123,339 | 122,980 | |||
Diluted | 123,914 | 124,042 | |||
Reportable Segment Information | |||||||||||||
(Unaudited) | |||||||||||||
Dollars in millions | |||||||||||||
Net sales | Earnings (losses) before income taxes | ||||||||||||
Three Months Ended | Three Months Ended | ||||||||||||
9/30/2022 | 9/30/2021 | % Change(1) | 9/30/2022 | 9/30/2021 | % Change(1) | ||||||||
Health and Wellness | $ | 712 | $ | 745 | (4) % | $ | 115 | $ | 105 | 10 % | |||
Household | 423 | 442 | (4) % | 22 | 36 | (39) % | |||||||
Lifestyle | 320 | 331 | (3) % | 60 | 93 | (35) % | |||||||
International | 285 | 288 | (1) % | 23 | 30 | (23) % | |||||||
Corporate | — | — | — | (104) | (79) | 32 % | |||||||
Total | $ | 1,740 | $ | 1,806 | (4) % | $ | 116 | $ | 185 | (37) % | |||
(1) Percentages based on rounded numbers. | |||||||||||||
Condensed Consolidated Balance Sheets | |||||||||||
Dollars in millions | |||||||||||
9/30/2022 | 6/30/2022 | 9/30/2021 | |||||||||
(Unaudited) | (Unaudited) | ||||||||||
ASSETS | |||||||||||
Current assets | |||||||||||
Cash and cash equivalents | $ | 278 | $ | 183 | $ | 210 | |||||
Receivables, net | 612 | 681 | 654 | ||||||||
Inventories, net | 755 | 755 | 785 | ||||||||
Prepaid expenses and other current assets | 118 | 106 | 171 | ||||||||
Total current assets | 1,763 | 1,725 | 1,820 | ||||||||
Property, plant and equipment, net | 1,322 | 1,334 | 1,301 | ||||||||
Operating lease right-of-use assets | 336 | 342 | 310 | ||||||||
Goodwill | 1,546 | 1,558 | 1,566 | ||||||||
Trademarks, net | 685 | 687 | 691 | ||||||||
Other intangible assets, net | 190 | 197 | 218 | ||||||||
Other assets | 311 | 315 | 368 | ||||||||
Total assets | $ | 6,153 | $ | 6,158 | $ | 6,274 | |||||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||
Current liabilities | |||||||||||
Notes and loans payable | $ | 348 | $ | 237 | $ | 86 | |||||
Current maturities of long-term debt | — | — | 899 | ||||||||
Current operating lease liabilities | 78 | 78 | 72 | ||||||||
Accounts payable and accrued liabilities | 1,584 | 1,469 | 1,582 | ||||||||
Total current liabilities | 2,010 | 1,784 | 2,639 | ||||||||
Long-term debt | 2,475 | 2,474 | 1,885 | ||||||||
Long-term operating lease liabilities | 308 | 314 | 288 | ||||||||
Other liabilities | 805 | 791 | 846 | ||||||||
Deferred income taxes | 59 | 66 | 69 | ||||||||
Total liabilities | 5,657 | 5,429 | 5,727 | ||||||||
Stockholders' equity | |||||||||||
Preferred stock | — | — | — | ||||||||
Common stock | 131 | 131 | 131 | ||||||||
Additional paid-in capital | 1,193 | 1,202 | 1,166 | ||||||||
Retained earnings | 832 | 1,048 | 1,027 | ||||||||
Treasury stock | (1,315) | (1,346) | (1,389) | ||||||||
Accumulated other comprehensive net (loss) income | (515) | (479) | (567) | ||||||||
Total Clorox stockholders' equity | 326 | 556 | 368 | ||||||||
Noncontrolling interests | 170 | 173 | 179 | ||||||||
Total stockholders' equity | 496 | 729 | 547 | ||||||||
Total liabilities and stockholders' equity | $ | 6,153 | $ | 6,158 | $ | 6,274 | |||||
View original content to download multimedia:https://www.prnewswire.com/news-releases/clorox-reports-q1-fiscal-year-2023-results-confirms-outlook-301664002.html
SOURCE The Clorox Company
FAQ
What were Clorox's net sales for Q1 FY2023?
How much did Clorox's diluted EPS decline in Q1 FY2023?
What is Clorox's outlook for net sales in FY2023?
What were the primary factors contributing to Clorox's sales decline in Q1 FY2023?
How much did Clorox's gross margin decrease in Q1 FY2023?
